Roswell Park Cancer Institiute is a clinical research site located in Buffalo, New York, United States 14263.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Roswell Park Cancer Institiute has participated in 1 clinical trials.
Therapeutic areas: Acute Myeloid Leukemia.
Sponsors: Cyclacel Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Roswell Park Cancer Institiute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Roswell Park Cancer Institiute has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia.
Roswell Park Cancer Institiute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.